Costs of Cervical Disc Replacement Versus Anterior Cervical Discectomy and Fusion for Treatment of Single-Level Cervical Disc Disease

作者
Kris E. Radcliff,J.D. Zigler,Jack E. Zigler
出处
期刊:Spine [Lippincott Williams & Wilkins]
卷期号:40 (8): 521-529 被引量:68
标识
DOI:10.1097/brs.0000000000000822
摘要

STUDY DESIGN: Retrospective review of prospectively collective administrative data. OBJECTIVE: The purpose of this study was to determine the reoperation rates, adverse event rate, as well as the direct and follow-on costs of cervical disc arthroplasty (CDA) compared with anterior cervical discectomy and fusion (ACDF) in a "real-world" population of patients with single-level symptomatic cervical disc disease. SUMMARY OF BACKGROUND DATA: Until very recently, there was a paucity of human clinical data to demonstrate that CDA lowers the rate of adjacent segment disease over ACDF. METHODS: This was a retrospective, matched cohort analysis of a prospectively collected database of costs and outcomes for patients aged 18 to 60 years, who were continuously enrolled in a Blue Cross Plan contributing data to a claims database. Inclusion criteria were as follows: all patients who were treated surgically with either CDA or ACDF between January 2008 and December 2009, with single-level cervical pathology and claims reflecting at least 6 weeks of nonsurgical preoperative care without claims history of prior surgery. RESULTS: There were 6635 ACDF patients and 327 CDA patients. There were no significant differences in the incidence of comorbidities or mean follow-up time (ACDF 25.7 mo vs. CDA 26.1 mo) between groups. By 36 months postoperatively, the reoperation rate was significantly increased in the ACDF group (10.5%) versus the CDA group (5.7%) (hazard ratio, P = 0.0214). The index surgery and 90-day global window costs were significantly lower in the CDA groups. At final follow-up, there was a statistically significant reduction in total costs paid by insurer in CDA patients (CDA $34,979 vs. ACDF $39,820). CONCLUSION: Patients who underwent CDA for single-level degenerative disease had lower readmission rates, lower reoperation rates, and reduced index and total costs than those treated with ACDF. CDA was effective in reducing the monthly cost of care compared with ACDF. LEVEL OF EVIDENCE: 2.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
PEIHENG完成签到 ,获得积分10
1秒前
小熊完成签到,获得积分10
1秒前
CarryLJR的应助被周周周周周采纳,获得10
1秒前
英俊的铭的应助被envir采纳,获得10
1秒前
1秒前
eiland发布了新的文献求助10
2秒前
CarryLJR的应助被Roseaiwade采纳,获得10
2秒前
2秒前
2秒前
tang发布了新的文献求助10
2秒前
方超完成签到,获得积分10
3秒前
无限水杯完成签到,获得积分10
4秒前
李健的小迷弟的应助被晚风采纳,获得10
4秒前
4秒前
小马甲的应助被罗伯特骚塞采纳,获得10
5秒前
棉花糖发布了新的文献求助10
5秒前
机灵柚子的应助被笑点低凝荷采纳,获得20
5秒前
5秒前
MingQue发布了新的文献求助10
6秒前
maT发布了新的文献求助10
6秒前
6秒前
李健的应助被滕滕滕采纳,获得10
6秒前
6秒前
果粒橙发布了新的文献求助10
7秒前
直率万声发布了新的文献求助10
7秒前
ygchyh完成签到,获得积分10
7秒前
默默发布了新的文献求助10
7秒前
满意的天完成签到 ,获得积分10
7秒前
banana95完成签到 ,获得积分10
7秒前
8秒前
xkuz完成签到,获得积分10
9秒前
10秒前
10秒前
Orange的应助被孙朱珠采纳,获得10
10秒前
景碧空完成签到 ,获得积分10
12秒前
wangbw发布了新的文献求助10
12秒前
13秒前
灿烂sunfly完成签到,获得积分10
13秒前
13秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
Grapes 1000
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8178807
求助须知:如何正确求助?哪些是违规求助? 9569558
关于积分的说明 21805222
捐赠科研通 7773974
什么是DOI,文献DOI怎么找? 3432933
关于科研通互助平台的介绍 2556873
邀请新用户注册赠送积分活动 2478593